Latest Interviews
Showing 2071–2085 of 3,000 transcripts.
Clear all filters- Milken Institute1h 0m
Driving the Digital Health Revolution
Indu Subaiya, Paul Chew, Karen DeSalvo, Esther Dyson, Cindy Elkins, Donald Jones, Don Jones
The digital health sector is pivoting from episodic treatment to preventative "generating health" models, driven by a projected shortage of 40,000 primary care physicians by 2030 and the need to address social determinants that account for 80% of health outcomes. Companies like Omada Health and Way to Wellville are disrupting traditional fee-for-service structures by implementing value-based payment reforms that leverage behavioral design, remote coaching, and community-led interventions to achieve measurable clinical results. Despite significant funding and technological advancements in AI and connected devices, widespread adoption faces critical hurdles including regulatory lag, the digital divide, and the need for new data ownership frameworks to support equitable population health management.
- Milken Institute1h 0m
Raising an Active Generation
Sean Gregory, Mark Abbott, Eric Boerwinkle, Bruce Y. Lee, Kathleen Tullie
Discussions highlight how a $15 billion youth sports industry and restrictive school policies have created significant health disparities and participation gaps for children in lower-income neighborhoods. To address these systemic barriers, stakeholders including the MLS, Reebok, and corporate partners are deploying grassroots solutions such as free mini-pitches, sampling-based training programs, and mobile donation initiatives to increase accessibility and physical literacy. These strategic shifts prioritize unstructured play, injury prevention, and inclusive recreational leagues to counteract burnout and ensure long-term retention across diverse communities.
- a16z29 min
The Future of Money: Banking on Fintech
The financial sector is undergoing a fundamental transformation where revenue is decoupling from physical branches as fintech startups disrupt the $12 trillion lending market and traditional insurance models through specialized digital services. While legacy institutions like Chase and Wells Fargo retain distribution advantages that often force startups to pivot toward B2B technology sales or niche verticals, innovation continues to accelerate via automated underwriting and alternative data sources. This competitive dynamic establishes that success now hinges on owning consumer relationships or critical infrastructure layers rather than competing directly on broad banking products.
- Milken Institute35 min
A Conversation with FDA Commissioner Scott Gottlieb
Former FDA Commissioner Scott Gottlieb outlines a multifaceted regulatory strategy addressing the opioid epidemic, tobacco addiction, and the aftermath of Hurricane María on Puerto Rico's critical medical manufacturing sector. He emphasizes adapting regulatory frameworks for emerging technologies like artificial intelligence and digital health tools while prioritizing the prevention of medical misinformation and product shortages. The discussion highlights a shift toward reducing review cycles, de-risking early-stage development, and utilizing post-market surveillance to balance safety with innovation.
- Milken Institute1h 2m
Women Leading a Wellness Revolution
Joyce Chang, Nancy Brinker, Alexia Brue, Donna Karan, Melanie Whelan
Moderated by Joyce Chang, a panel of industry leaders including Donna Karan, Nancy Brinker, Alexia Brew, and Melanie Whalen convened to redefine the wellness movement as a collaborative force driven by community accountability and shared impact. The discussion highlighted distinct strategies for systemic change, from SoulCycle's peer-driven transformation model and Well and Good's democratization of health journalism to Susan G. Komen's focus on closing care access gaps and Urban Zen's integration of holistic care within commercial and healthcare frameworks. Ultimately, the group agreed that the future of wellness relies on shifting resources from reactive "sick care" to preventative lifestyle solutions supported by clean data and scalable community networks.
- Milken Institute34 min
A Conversation with PepsiCo CEO Indra Nooyi
Indra Nooyi, Michael Milken, Andrew, Mike
PepsiCo CEO Indra Nooyi transformed the beverage and snack giant through "Performance with Purpose," a strategy that integrated social and environmental sustainability into core operations while shifting the revenue portfolio toward healthier product lines. This cultural overhaul was driven by scientific leadership under Chief Scientific Officer Dr. Mahmood Khan and reinforced by tying executive compensation to specific nutritional and environmental goals. Nooyi further extended the company's impact by forging partnerships with healthcare institutions to improve access for underserved veterans and advocating for systemic policy changes to address chronic disease and nutritional equity.
- Milken Institute1h 1m
Innovators Improving Access: Creating Healthier Links in the Food Chain
Kevin Boylan, Matt Barnard, Lee Anne Grant, Dariush Mozaffarian, Sam Polk, Josh Stevens, Simone Friedman, Jeffrey Davis, Ambassador Compson
Leading entrepreneurs from Everytable, Plenty, Day2, and Brandless, alongside Tufts University Dean Dr. Dari Mozaffarian, convened to debate scalable solutions for a U.S. food system that drives 70% of annual deaths through diet-related chronic disease. The panelists presented contrasting strategies ranging from Everytable's dual-tier pricing and Plenty's water-efficient vertical farming to Day2's machine learning-driven personalized nutrition, while challenging the federal government's $46-to-one research funding disparity between nutrition and pharmaceuticals. Ultimately, the discussion highlighted a critical pivot toward integrating healthy food into healthcare infrastructure and expanding global operations to address the 1,400 daily cardiovascular and diabetes deaths attributed to dietary factors.
- Milken Institute54 min
A State of Emergency: Integrative Approaches to Addiction and the Opioid Epidemic
David Beier, Jerome Adams, Terry McAuliffe, Lori McFarling, Tom Moriarty, Nora Volkow, Tammy Wincup
A federal and state coalition deployed 14,000 officials alongside private sector partners like CVS and Discovery Education to address the opioid crisis through prevention economics, educational outreach, and prescription limits that reduced Virginia's over-prescriptions by one-third. Initiatives including a new data-sharing compact among 46 governors and the Surgeon General's social capital report aim to leverage granular prescription analytics and community resilience to cut costs associated with incarceration and unemployment. These coordinated efforts target the multifactorial nature of the epidemic by embedding science-based prevention in classrooms, enforcing seven-day prescription caps, and expanding safe disposal programs to recover from 64,000 overdose deaths recorded in 2016.
- Milken Institute46 min
The Future of Health: A New World of Collaboration
Michael Milken, Francis Collins, Lynn Goldman, Bob Hugin
The National Institutes of Health, alongside corporate leaders like Celgene and academic institutions such as GW School of Public Health, is driving a decade-long strategic shift toward cross-sector collaboration to address mounting global health crises including opioid addiction, rising obesity-related cancers, and antimicrobial resistance. Key initiatives such as the Accelerating Medicines Partnership and the "All of Us" research program are deploying hundreds of millions in combined public and private funding to accelerate therapeutic discovery, leverage genomic data, and implement preventive structural interventions. This coordinated effort aims to reverse declining U.S. life expectancy trends and reduce the $4 trillion annual economic burden of chronic disease by aligning industry innovation cycles with public health objectives.
- Milken Institute1h 1m
Boundless Potential: How Unlocking Big Data Can Change Health
Dan Diamond, Murray Aitken, Aneesh Chopra, Martin J. Murphy, Robin Thurston
Industry leaders from Quintiles IMS, Helix, and the Obama administration convened to evaluate big data's transition from hype to a tangible reality that is currently constrained by fragmented data, misaligned financial incentives, and a cultural gap in healthcare adoption. The panel highlighted Project Data Sphere, which has grown into the world's largest open-access cancer trial database to enable synthetic control arms that could halve trial timelines and improve survival rates for small cell lung cancer. Looking forward, experts discussed how lowering sequencing costs, blockchain privacy tools, and shifting toward value-based payment models aim to overcome current silos and empower consumers to drive precision public health initiatives.
- Milken Institute48 min
A Conversation with FDA Commissioner Scott Gottlieb
Scott Gottlieb, Michael Milken, Indra Nooyi
This summit convened experts and FDA leadership to address critical public health challenges, including the link between sleep deprivation and obesity, the scaling of screen time interventions, and the opioid epidemic. Regulatory strategies were detailed for reducing opioid exposure through shorter prescription durations, while new tobacco policies aim to minimize nicotine addiction in combustible products and regulate youth-targeted vaping technologies. Additionally, the discussion covered FDA responses to supply chain disruptions in Puerto Rico following a hurricane and the development of regulatory frameworks for emerging digital health and artificial intelligence tools.
- Milken Institute43 min
Putting Prevention First
Liz Szabo, Kelly Close, William Dietz, Frank Hu, Anne Schuchat, Hugh Waters, Bill Dietz
Recent data reveals that US obesity rates continue to rise across all demographics, with annual prevalence increasing by 1% for decades and severe disparities affecting over half of African American and Hispanic women. These trends drive a $3.4 trillion annual economic burden and sharply increase risks for diabetes, cardiovascular disease, and 13 types of cancer, prompting experts to shift focus from treating established obesity to preventing weight gain in young adults through environmental changes and policy reform.
- Milken Institute1h 9m
A State of Emergency: Integrative Approaches to Addiction and the Opioid Epidemic
David Beier, Jerome Adams, Terry McAuliffe, Lori McFarling, Tom Moriarty, Nora Volkow, Tammy Wincup, Indra Nooyi, Scott Gottlieb
Federal and state leaders are mobilizing a multi-sector response to the opioid crisis, deploying 14,000 officials while partnering with organizations like CVS and Discovery Education to expand prevention education and pharmaceutical take-back programs. This coordinated strategy integrates clinical data, economic recovery initiatives, and new state-level regulations, such as Virginia's prescription limits, to address the 22% surge in overdose deaths and the underlying social determinants driving addiction. Stakeholders are urged to audit medicine cabinets and commit to shared resource distribution, aiming to transition from reactive emergency measures to proactive community resilience through improved health infrastructure and data analytics.
- Milken Institute1h 38m
A Conversation with Ray Dalio and Michael Milken
Ray Dalio outlines his journey from a 1960s caddie to the architect of Bridgewater's "idea meritocracy," a philosophy forged after a costly 1982 sovereign debt mistake forced him to prioritize objective disagreement over ego. Drawing on historical cycles like the 1974 market crash and 1937 recession, Dalio warns of current parallels in wealth disparity and pension funding gaps while critiquing Bitcoin as a speculative bubble despite China's engineering strengths. His analysis concludes that future economic resilience depends on radical transparency, automation-ready skills, and recognizing that sustainable wealth is a byproduct of value creation rather than an end goal.
- Milken Institute1h 1m
Feeding the Planet: Innovations in Food and Agriculture
Sharanjit Leyl, Jeremy Coller, David Lee, Beverley Postma, Jason Strong
Addressing the projected demand of 2 billion additional people by 2030, a panel of investors and industry leaders including David Lee of Impossible Foods and Jeremy Grantham outlined a dual strategy combining radical plant-based disruption with incremental efficiency gains in existing livestock systems. The discussion highlighted that while biofortification by Harvest Plus offers a 1:17 return on investment to combat malnutrition, the global food revolution depends on achieving cost parity for technologies like heme-based meats and clean meat at scale. Ultimately, the consensus identified $65 trillion in responsible investment capital and a breakdown of institutional silos between finance, health, and agriculture as the necessary catalysts to drive this market-led sustainability transition.